Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases: A Prospective Case-Control Study

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Age 18 years and older.

• Diagnosed with one of the specified pulmonary diseases, or a healthy control

• Able to provide written informed consent

Locations
Other Locations
Egypt
Assiut University- Faculty of Medicine
RECRUITING
Asyut
Contact Information
Primary
Ahmad M. Shaddad, MD
shaddad_ahmad@yahoo.com
+201111171930
Time Frame
Start Date: 2025-05-30
Estimated Completion Date: 2026-03-01
Participants
Target number of participants: 700
Treatments
COPD
Chronic obstructive pulmonary disease patients will be further classified as mild, moderate, severe, and very severe according to GOLD classification.
Pneumothorax
Patients with Pneumothorax
CAP
Community-acquired pneumonia will be classified using the CURB-65 score into mild, moderate, and severe.
ILDs
Interstitial lung diseases will be further classified using FVC% classes, categorized as mild, moderate, and severe.
Bronchiectasis
patients with non-cystic fibrosis bronchiectasis
Pleural Effusion
Patients with pleural effusion
Pulmonary Oedema
Patient with any degree of Pulmonary oedema
Control
Healthy control subjects for comparison
Sponsors
Leads: Assiut University
Collaborators: Aliae AR Mohamed Hussein [ahussein

This content was sourced from clinicaltrials.gov